Literature DB >> 16827895

E prostanoid 2 (EP2)/EP4-mediated suppression of antigen-specific human T-cell responses by prostaglandin E2.

Mitsuhiro Okano1, Yuji Sugata, Tazuko Fujiwara, Rie Matsumoto, Masahiro Nishibori, Kenji Shimizu, Megumi Maeda, Yoshinobu Kimura, Shin Kariya, Hisashi Hattori, Minehiko Yokoyama, Kosuke Kino, Kazunori Nishizaki.   

Abstract

Prostaglandin E2 (PGE2) is a lipid mediator that displays important immunomodulatory properties, such as polarization of cytokine production by T cells. Recent investigations have revealed that the effect of PGE2 on cytokine production is greatly influenced by external stimuli; however, it is unclear whether PGE2 plays a significant role in major histocompatibility complex-mediated antigen-specific T-cell responses via binding to one of four subtypes of E prostanoid (EP) receptor alone or in combination. In the present study, we sought to determine the effect of PGE2 on antigen-specific CD4+ T-cell responses in humans, especially in terms of receptor specificity. We used purified protein derivative (PPD) and Cry j 1 as T helper type 1 (Th1) and Th2-inducing antigens, respectively. We generated several different Cry j 1- and PPD-specific T-cell lines (TCLs). PGE2 significantly and dose-dependently inhibited the proliferation and subsequent production of interleukin-4 by Cry j 1-specific TCLs and of interferon-gamma by PPD-specific TCLs upon antigen stimulation. Administration of EP2 receptor agonist and EP4 receptor agonist suppressed these responses in an adenylate cyclase-dependent manner, while EP1 and EP3 receptor agonists did not. Messenger RNA for EP2, EP3 and EP4, but not EP1, receptors were detected in Cry j 1- and PPD-specific TCLs, and no differences in EP receptor expression were observed between them. Furthermore, PGE2 and EP2 receptor agonist significantly inhibited interleukin-5 and interferon-gamma production by peripheral blood mononuclear cells in response to Cry j 1 and PPD stimulation, respectively. These results suggest that PGE2 suppresses both Th1- and Th2-polarized antigen-specific human T-cell responses via a cAMP-dependent EP2/EP4-mediated pathway.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16827895      PMCID: PMC1782299          DOI: 10.1111/j.1365-2567.2006.02376.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  34 in total

Review 1.  Regulation of asthma-related T-cell cytokines by the cyclic AMP-dependent signalling pathway.

Authors:  P Borger; D S Postma; E Vellenga; H F Kauffman
Journal:  Clin Exp Allergy       Date:  2000-07       Impact factor: 5.018

2.  Differential role of CD80 and CD86 molecules in the induction and the effector phases of allergic rhinitis in mice.

Authors:  M Okano; M Azuma; T Yoshino; H Hattori; M Nakada; A R Satoskar; D A Harn; E Nakayama; T Akagi; K Nishizaki
Journal:  Am J Respir Crit Care Med       Date:  2001-10-15       Impact factor: 21.405

3.  Roles of carbohydrates on Cry j 1, the major allergen of Japanese cedar pollen, in specific T-cell responses.

Authors:  M Okano; K Kino; T Takishita; H Hattori; T Ogawa; T Yoshino; M Yokoyama; K Nishizaki
Journal:  J Allergy Clin Immunol       Date:  2001-07       Impact factor: 10.793

4.  Prostaglandin E2 selectively inhibits human CD4+ T cells secreting low amounts of both IL-2 and IL-4.

Authors:  X He; J M Stuart
Journal:  J Immunol       Date:  1999-12-01       Impact factor: 5.422

5.  Sex-related differences in the initiation of allergic rhinitis in mice.

Authors:  T Yamatomo; M Okano; T Ono; E Nakayama; T Yoshino; A R Satoskar; D A Harn ; K Nishizaki
Journal:  Allergy       Date:  2001-06       Impact factor: 13.146

Review 6.  Prostaglandins as modulators of immunity.

Authors:  Sarah G Harris; Josue Padilla; Laura Koumas; Denise Ray; Richard P Phipps
Journal:  Trends Immunol       Date:  2002-03       Impact factor: 16.687

7.  Intranasal application of purified protein derivative suppresses the initiation but not the exacerbation of allergic rhinitis in mice.

Authors:  H Hattori; M Okano; T Yamamoto; T Yoshino; Y Yamashita; T Watanabe; A R Satoskar; D A Harn; K Nishizaki
Journal:  Clin Exp Allergy       Date:  2002-06       Impact factor: 5.018

8.  Expressions of cyclooxygenase-2 and prostaglandin E-receptors in carcinoma of the gallbladder: crucial role of arachidonate metabolism in tumor growth and progression.

Authors:  Toru Asano; Junichi Shoda; Tetsuya Ueda; Toru Kawamoto; Takeshi Todoroki; Manabu Shimonishi; Tadashi Tanabe; Yukihiko Sugimoto; Atsushi Ichikawa; Michihiro Mutoh; Naomi Tanaka; Masanao Miwa
Journal:  Clin Cancer Res       Date:  2002-04       Impact factor: 12.531

9.  Prostaglandin E(2) inhibits IL-18-induced ICAM-1 and B7.2 expression through EP2/EP4 receptors in human peripheral blood mononuclear cells.

Authors:  Hideo K Takahashi; Hiromi Iwagaki; Tadashi Yoshino; Shuji Mori; Toshihiko Morichika; Hideyuki Itoh; Minori Yokoyama; Shinichiro Kubo; Eisaku Kondo; Tadaatsu Akagi; Noriaki Tanaka; Masahiro Nishibori
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

10.  Receptors for prostaglandin E(2) that regulate cellular immune responses in the mouse.

Authors:  C Nataraj; D W Thomas; S L Tilley; M T Nguyen; R Mannon; B H Koller; T M Coffman
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

View more
  32 in total

1.  Prostaglandin E₂ increases fibroblast gene-specific and global DNA methylation via increased DNA methyltransferase expression.

Authors:  Steven K Huang; Anne M Scruggs; Jake Donaghy; Richard C McEachin; Aaron S Fisher; Bruce C Richardson; Marc Peters-Golden
Journal:  FASEB J       Date:  2012-05-29       Impact factor: 5.191

2.  Navigating the leukocyte signaling maze guided by Ariadne's thread.

Authors:  Amnon Altman; Gary A Koretzky; Constantine D Tsoukas
Journal:  Nat Immunol       Date:  2009-11       Impact factor: 25.606

3.  Prostaglandin transporter, SLCO2A1, mediates the invasion and apoptosis of lung cancer cells via PI3K/AKT/mTOR pathway.

Authors:  Qiaoliang Zhu; Xiang Liang; Jing Dai; Xin Guan
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

4.  A Second Generation Prostanoid Receptor Antagonist Acting at Multiple Receptor Subtypes.

Authors:  David F Woodward; Jenny W Wang; Clayton S Spada; Robert W Carling; Jose L Martos; Simon Pettit; Jussi Kangasmetsa; L David Waterbury; Matthew Lawrence; Wenzheng Hu; Neil J Poloso
Journal:  ACS Pharmacol Transl Sci       Date:  2020-10-26

5.  A novel antagonist of the prostaglandin E(2) EP(4) receptor inhibits Th1 differentiation and Th17 expansion and is orally active in arthritis models.

Authors:  Q Chen; K Muramoto; N Masaaki; Y Ding; H Yang; M Mackey; W Li; Y Inoue; K Ackermann; H Shirota; I Matsumoto; M Spyvee; S Schiller; T Sumida; F Gusovsky; M Lamphier
Journal:  Br J Pharmacol       Date:  2010-05       Impact factor: 8.739

6.  Prostaglandin E₂ suppresses allergic sensitization and lung inflammation by targeting the E prostanoid 2 receptor on T cells.

Authors:  Zbigniew Zasłona; Katsuhide Okunishi; Emilie Bourdonnay; Racquel Domingo-Gonzalez; Bethany B Moore; Nicholas W Lukacs; David M Aronoff; Marc Peters-Golden
Journal:  J Allergy Clin Immunol       Date:  2013-09-24       Impact factor: 10.793

7.  An important role of prostanoid receptor EP2 in host resistance to Mycobacterium tuberculosis infection in mice.

Authors:  Vandana Kaul; Debapriya Bhattacharya; Yogesh Singh; Luc Van Kaer; Marc Peters-Golden; William R Bishai; Gobardhan Das
Journal:  J Infect Dis       Date:  2012-10-02       Impact factor: 5.226

8.  Bacterial lipopolysaccharide induces an endocrine switch from prostaglandin F2alpha to prostaglandin E2 in bovine endometrium.

Authors:  Shan Herath; Sonia T Lilly; Deborah P Fischer; Erin J Williams; Hilary Dobson; Clare E Bryant; I Martin Sheldon
Journal:  Endocrinology       Date:  2008-12-04       Impact factor: 4.736

9.  The role of prostaglandin E2 (PGE 2) in toll-like receptor 4 (TLR4)-mediated colitis-associated neoplasia.

Authors:  Yasmin Hernandez; John Sotolongo; Keith Breglio; Daisy Conduah; Anli Chen; Ruliang Xu; David Hsu; Ryan Ungaro; Lory A Hayes; Cristhine Pastorini; Maria T Abreu; Masayuki Fukata
Journal:  BMC Gastroenterol       Date:  2010-07-16       Impact factor: 3.067

10.  Activity of the cyclooxygenase 2-prostaglandin-E prostanoid receptor pathway in mice exposed to house dust mite aeroallergens, and impact of exogenous prostaglandin E2.

Authors:  Aida Herrerias; Rosa Torres; Mariona Serra; Alberto Marco; Laura Pujols; César Picado; Fernando de Mora
Journal:  J Inflamm (Lond)       Date:  2009-10-30       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.